CSP
6 min read
22

Karnov Group reports third quarter results 2024

November 6, 2024
0

Reading Time: 4 minutes Margin expansion, new AI solutions and launching next phase of the integration Financial highlights third quarter The Group’s net sales increased by 4.7% to SEK 648 m (619). Organic growth (constant currency) was 2.4%. Currency effect was -2.4%. Acquired growth was

Continue Reading
CSP
4 min read
9

Kesko updates its sustainability strategy

November 6, 2024
0

Reading Time: 3 minutes Kesko has updated its sustainability strategy, setting emission reduction targets for its own operations extending to 2034. Over the next 10 years, Kesko will be increasing its investments in energy efficiency and the electrification of transports in an effort to reduce emissions.

Continue Reading
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BWI
14 min read
34

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

November 6, 2024
0

Reading Time: 11 minutes San Mateo, Calif., United States:   Five-year results of Phase 3 SEQUOIA study demonstrate durable benefits of BRUKINSA in patients with CLL Two oral presentations showcase promising safety and efficacy data for BTK chimeric degradation activation compound (CDAC), BGB-16673 Oral presentation highlights

Continue Reading
CSP
10 min read
9

DUG Foodtech announces the outcome of the rights issue

November 6, 2024
0

Reading Time: 7 minutes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR

Continue Reading
Diageo India Releases 2024 ESG Reporting Index Highlights Achievements Across Its ‘Spirit of Progress’ Goals
BWI
9 min read
31

Diageo India Releases 2024 ESG Reporting Index Highlights Achievements Across Its ‘Spirit of Progress’ Goals

November 6, 2024
0

Reading Time: 6 minutes ​ Diageo India (United Spirits Ltd.), among the country’s leading alco-bev companies, launched its third annual ESG Reporting Index 2024 today, highlighting continued progress in the company’s ‘Spirit of Progress’ ESG action plan. The Reporting Index shares impacts across three key objectives outlined in Diageo’s Spirit

Continue Reading
OCBC Forms Strategic Partnership With Ant International to Enhance the Efficiency of Cross-Border Fund Settlements Through Innovations in Tokenised Deposits
BWI
4 min read
31

OCBC Forms Strategic Partnership With Ant International to Enhance the Efficiency of Cross-Border Fund Settlements Through Innovations in Tokenised Deposits

November 6, 2024
0

Reading Time: 3 minutes Singapore:   OCBC and Ant International have formed a strategic partnership to enhance the efficiency and speed of cross-border fund settlements. In a Memorandum of Understanding (MoU) signed on 5 November 2024 by Melvyn Low, Head of Global Transaction Banking at OCBC,and

Continue Reading
CSP
1 min read
17

#24-379 Listing of Derivatives at NGM

November 6, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
15

#24-380 Delisting of Derivatives from NGM

November 6, 2024
0

Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized

Continue Reading
CSP
3 min read
20

BLA for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) accepted for priority review by the U.S. FDA

November 6, 2024
0

Reading Time: 2 minutes Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders

Continue Reading
SOFTSWISS Wins SBC Latinoamérica Award for Help Brazil Initiative
CSP
2 min read
21

SOFTSWISS Wins SBC Latinoamérica Award for Help Brazil Initiative

November 6, 2024
0

Reading Time: 2 minutes SOFTSWISS has won the Socially Responsible Initiative of the Year nomination at the SBC Awards Latinoamérica 2024 for its impactful ‘Help Brazil’ initiative. This recognition underscores the company’s support for Brazilian communities affected by severe flooding earlier this year and its dedication to

Continue Reading